Perinatal exposures and kawasaki disease in Washington State: A population-based, case-control study

Pediatric Infectious Disease Journal

Volumn 31, Issue 10, 2012, Pages 1027-1031

  Hayward, Kristen ^a   Wallace, Carol A ^a   Koepsell, Thomas ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

birth certificates; case control study; epidemiology; Kawasaki disease; risk factors

Indexed keywords

ADOLESCENT; ADULT; AMERICAN INDIAN; ARTICLE; ASIAN; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BIRTH CERTIFICATE; CASE CONTROL STUDY; CAUSE OF DEATH; CHILD; CHORIOAMNIONITIS; DIABETES MELLITUS; DISEASE ASSOCIATION; ECLAMPSIA; ENVIRONMENTAL EXPOSURE; FEMALE; GENDER; GESTATIONAL AGE; HISPANIC; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERBILIRUBINEMIA; HYPERTENSION; JAUNDICE; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MECONIUM ASPIRATION; MEDICAL RECORD REVIEW; MUCOCUTANEOUS LYMPH NODE SYNDROME; PERINATAL PERIOD; POPULATION RESEARCH; PREECLAMPSIA; PRENATAL EXPOSURE; PRENATAL PERIOD; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SEPSIS; STREPTOCOCCUS AGALACTIAE; VIRUS INFECTION;

ADULT; BACTERIAL INFECTIONS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RETROSPECTIVE STUDIES; WASHINGTON; YOUNG ADULT;

EID: 84866629891     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31825eaed0     Document Type: Article

References (45)

1. Davis RL, Waller PL, Mueller BA, et al. Kawasaki syndrome in Washington State. Race-specifc incidence rates and residential proximity to water. Arch Pediatr Adolesc Med. 1995;149:66-69.
2. Chang RK. Hospitalizations for Kawasaki disease among children in the United States, 1988-1997. Pediatrics. 2002;109:e87.
3. Holman RC, Curns AT, Belay ED, et al. Kawasaki syndrome hospitaliza-tions in the United States, 1997 and 2000. Pediatrics. 2003;112(3 Pt 1): 495-501.
4. Council on Cardiovascular Disease in the Young, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, American Heart Association. Diagnostic guidelines for Kawasaki disease. Circulation. 2001;103: 335-336.
5. Morens DM, Anderson LJ, Hurwitz ES. National surveillance of Kawasaki disease. Pediatrics. 1980;65:21-25.
6. Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation. 1993;87:1776-1780.
7. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10-to 21-year follow-up study of 594 patients. Circulation. 1996;94:1379-1385.
8. Newburger J W, Takahashi M, Gerber MA, et al.; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114:1708-1733.
9. Belay ED, Holman RC, Clarke MJ, et al. The incidence of Kawasaki syndrome in West Coast health maintenance organizations. Pediatr Infect Dis J. 2000;19:828-832.
10. Terai M, Shulman ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr. 1997;131:888-893.
11. Belay ED, Holman RC, Maddox RA, et al. Kawasaki syndrome hospi-talizations and associated costs in the United States. Public Health Rep. 2003;118:464-469.
12. Taubert KA, Rowley AH, Shulman ST. Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J. 1994;13: 704-708.
13. Sève P, Stankovic K, Smail A, et al. Adult Kawasaki disease: report of two cases and literature review. Semin Arthritis Rheum. 2005;34:785-792.
14. Barker DJ. The fetal origins of diseases of old age. Eur J Clin Nutr. 1992;46(suppl 3):S3-S9.
15. Martel MJ, Rey E, Malo JL, et al. Determinants of the incidence of childhood asthma: a two-stage case-control study. Am J Epidemiol. 2009;169:195-205.
16. Metsälä J, Kilkkinen A, Kaila M, et al. Perinatal factors and the risk of asthma in childhood-a population-based register study in Finland. Am J Epidemiol. 2008;168:170-178.
17. D'Angeli MA, Merzon E, Valbuena LF, et al. Environmental factors associated with childhood-onset type 1 diabetes mellitus: an exploration of the hygiene and overload hypotheses. Arch Pediatr Adolesc Med. 2010;164:732-738.
18. Alm B, Erdes L, Möllborg P, et al. Neonatal antibiotic treatment is a risk factor for early wheezing. Pediatrics. 2008;121:697-702.
19. Kumar R. Prenatal factors and the development of asthma. Curr Opin Pedi-atr. 2008;20:682-687.
20. Williams RL, Creasy RK, Cunningham GC, et al. Fetal growth and perinatal viability in California. Obstet Gynecol. 1982;59:624-632.
21. Rowley AH, Wolinsky SM, Relman DA, et al. Search for highly conserved viral and bacterial nucleic acid sequences corresponding to an etiologic agent of Kawasaki disease. Pediatr Res. 1994;36:567-571.
22. Turkay S, Odemis E, Karadag A. Kawasaki disease onset during concomitant infections with varicella zoster and Epstein-Barr virus. J Natl Med Assoc. 2006;98:1350-1352.
23. Yanase Y, Tango T, Okumura K, et al. A comparative study of alteration in lymphocyte subsets among varicella, hand-foot-and-mouth disease, scarlet fever, measles, and Kawasaki disease. Microbiol Immunol. 1987;31:701-710.
24. Yoshikawa T, Ihira M, Suzuki K, et al. Human herpesvirus 8 is not associated with Kawasaki disease. Pediatr Infect Dis J. 1998;17:1179.
25. Brogan PA, Shah V, Clarke LA, et al. T cell activation profles in Kawasaki syndrome. Clin Exp Immunol. 2008;151:267-274.
26. Leung DY, Meissner HC, Shulman ST, et al. Prevalence of superan-tigen-secreting bacteria in patients with Kawasaki disease. J Pediatr. 2002;140:742-746.
27. Rowley AH, Baker SC, Shulman ST, et al. RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease. PLoS ONE. 2008;3:e1582.
28. Nomura Y, Masuda K, Yoshinaga M, et al. Possible relationship between streptococcal pyrogenic exotoxin A and Kawasaki syndrome in patients older than six months of age. Pediatr Infect Dis J. 2003;22:794-798.
29. Onouchi Y. Molecular genetics of Kawasaki disease. Pediatr Res. 2009;65(5 Pt 2):46R-54R.
30. Yeung RS. Kawasaki disease: update on pathogenesis. Curr Opin Rheuma-tol. 2010;22:551-560.
31. Matsubara K, Fukaya T, Miwa K, et al. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease. Clin Exp Immunol. 2006;143:427-434.
32. Kummeling I, Stelma F F, Dagnelie PC, et al. Early life exposure to antibiotics and the subsequent development of eczema, wheeze, and allergic sensiti-zation in the frst 2 years of life: the KOALA Birth Cohort Study. Pediatrics. 2007;119:e225-e231.
33. Marra F, Lynd L, Coombes M, et al. Does antibiotic exposure during infancy lead to development of asthma?: a systematic review and metaanalysis. Chest. 2006;129:610-618.
34. Kozyrskyj AL, Ernst P, Becker AB. Increased risk of childhood asthma from antibiotic use in early life. Chest. 2007;131:1753-1759.
35. Marra F, Marra CA, Richardson K, et al. Antibiotic use in children is associated with increased risk of asthma. Pediatrics. 2009;123:1003-1010.
36. Eichenwald EC. Perinatally transmitted neonatal bacterial infections. Infect Dis Clin North Am. 1997;11:223-239.
37. Centers for Disease Control and Prevention. Perinatal group B streptococcal disease after universal screening recommendations\United States, 2003-2005. MMWR Morb Mortal Wkly Rep. 2007;56:701-705.
38. Centers for Disease Control and Prevention. Trends in perinatal group B streptococcal disease\United States, 2000-2006. MMWR Morb Mortal Wkly Rep. 2009;58:109-112.
39. Nomura Y, Yoshinaga M, Masuda K, et al. Maternal antibody against toxic shock syndrome toxin-1 may protect infants younger than 6 months of age from developing Kawasaki syndrome. J Infect Dis. 2002;185:1677-1680.
40. Baker CJ, Webb BJ, Kasper DL, et al. The natural history of group B strep-tococcal colonization in the pregnant woman and her offspring. II. Determination of serum antibody to capsular polysaccharide from type III, group B Streptococcus. Am J Obstet Gynecol. 1980;137:39-42.
41. Flores AE, Nelson JA, Wu XY, et al. Antibody profles to the group B streptococcal beta antigen in maternal and infant paired sera. APMIS. 1993;101:41-49.
42. Cardwell CR, Carson DJ, Patterson CC. Parental age at delivery, birth order, birth weight and gestational age are associated with the risk of childhood Type 1 diabetes: a UK regional retrospective cohort study. Diabet Med. 2005;22:200-206.
43. Haynes A, Bower C, Bulsara MK, et al. Perinatal risk factors for childhood Type 1 diabetes in Western Australia\a population-based study (1980-2002). Diabet Med. 2007;24:564-570.
44. Schrag S, Gorwitz R, Fultz-Butts K, et al. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002;51(RR-11):1-22.
45. American College of Obstetricians and Gynecologists. ACOG committee opinion: number 279, December 2002. Prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol. 2002;100:1405-1412.